ERBB2 and triple-negative breast carcinoma: In HER2-positive and triple-negative breast cancer tissues, expression of SDF-1α was significantly higher than in luminal A and luminal B subtypes, but there is no difference in SDF-1α expression between luminal A and luminal B subtypes or between HER2-positive and triple-negative breast cancer cells [28].